lercanidipine has been researched along with enalapril in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (23.68) | 29.6817 |
| 2010's | 27 (71.05) | 24.3611 |
| 2020's | 2 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Cleophas, TJ; van der Meulen, J; van Ouwerkerk, BM; Zwinderman, AH | 1 |
| Agrawal, R; Haller, H; Marx, A | 1 |
| Hair, PI; Perry, CM; Scott, LJ | 1 |
| Calvo, C; Ghezzi, C; Luurila, H; Luurila, O; Puig, JG; Strandberg, A; Sulosaari, S | 1 |
| Haller, H; Menne, J | 1 |
| Barrios, V; Echarri, R; Escobar, C | 1 |
| Chin, D; Ferrucci, A; Pagannone, E; Palano, F; Tocci, G; Volpe, M | 1 |
| Chatzikyrkou, C; Haller, H; Menne, J | 1 |
| Burnier, M; Pruijm, M; Wuerzner, G | 1 |
| Rump, LC | 1 |
| Gumustas, M; Ozkan, SA; Sanli, N; Sanlı, S | 1 |
| Borghi, C; Cicero, AF | 1 |
| Bramlage, P; Kreutz, R; Scholze, J; Trenkwalder, P | 1 |
| Caimi, L; Cancarini, A; De Ciuceis, C; Duse, S; La Boria, E; Muiesan, ML; Paini, A; Ricotta, D; Rizzoni, D; Rosei, CA; Rosei, EA; Rossini, C; Ruggeri, G; Salvetti, M; Sarkar, A; Semeraro, F | 1 |
| Bianchi, L; Bonaventura, A; D'Angelo, A; Derosa, G; Fogari, E; Maffioli, P; Romano, D | 2 |
| Agabiti Rosei, E; De Ciuceis, C; Di Gregorio, J; Donini, C; Flati, V; La Boria, E; Pasini, E; Petroboni, B; Porteri, E; Rizzoni, D; Rossini, C; Rufo, A | 1 |
| Minushkina, LO | 1 |
| Maldonado, J; Pereira, T; Tavares, A | 1 |
| Chazova, I; Coca, A; Girerd, X; Haller, H; Mancia, G; Pauletto, P; Pupek-Musialik, D; Svyshchenko, Y | 1 |
| Arnaout, S | 1 |
| Angeloni, E; Lombardo, P; Pirelli, M; Refice, S; Vitaterna, A | 1 |
| Bruno, RM; Cartoni, G; Ferri, C; Ghiadoni, L; Grassi, D; Magagna, A; Stea, F; Taddei, S; Virdis, A | 1 |
| Gosteva, EV; Vasil'eva, LV | 1 |
| Chazova, I; Coca, A; Girerd, X; Haller, H; Mancia, G; Omboni, S; Parati, G; Pauletto, P; Pupek-Musialik, D; Svyshchenko, Y | 1 |
| Bombelli, M; Brambilla, G; Casati, A; Cuspidi, C; Grassi, G; Mancia, G; Pizzalla, DP; Riva, M; Seravalle, G | 1 |
| Rizzoni, D | 2 |
| Parati, G | 1 |
| Calvo, C; Espinel, E; Esteban, R; Macias, JF; Mateos, L; Robles, NR; Sobrino, J | 1 |
| Dimitriadis, K; Mani, I; Mantzouranis, E; Tousoulis, D; Tsioufis, C; Tsioufis, K | 1 |
| Antza, C; Kotsis, V; Stabouli, S | 1 |
| Agabiti Rosei, C; Agabiti Rosei, E; Bertacchini, F; Brami, V; Caletti, S; Coschignano, MA; De Ciuceis, C; Duse, S; Muiesan, ML; Paini, A; Petelca, A; Rizzoni, D; Rossini, C; Salvetti, M; Semeraro, F; Trapletti, V | 1 |
| Castiglioni, P; Faini, A; Omboni, S; Parati, G | 1 |
| Abdessayed, N; Anoun, J; Ben Salem, C; Ben-Sayed, N; Fathallah, N; Ouni, B; Slim, R | 1 |
| Corsini, A; Ferri, N; Pontremoli, R | 1 |
12 review(s) available for lercanidipine and enalapril
| Article | Year |
|---|---|
Fixed-dose combination lercanidipine/enalapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Dihydropyridines; Drug Combinations; Enalapril; Humans; Hypertension | 2007 |
Fixed-dose lercanidipine/enalapril for hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Dihydropyridines; Drug Combinations; Drug Interactions; Enalapril; Humans; Hypertension | 2008 |
Fixed combinations in the management of hypertension: perspectives on lercanidipine-enalapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Drug Combinations; Enalapril; Humans; Hypertension; Treatment Outcome | 2008 |
Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Dihydropyridines; Drug Combinations; Enalapril; Humans; Hypertension; Medication Adherence | 2009 |
The role of fixed-dose combinations in the management of hypertension: focus on lercanidipine-enalapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Dihydropyridines; Drug Combinations; Enalapril; Humans; Hypertension | 2009 |
Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Calcium Channel Blockers; Dihydropyridines; Drug Combinations; Enalapril; Humans; Hypertension | 2009 |
Rationale for the use of a fixed-dose combination in the management of hypertension: efficacy and tolerability of lercanidipine/enalapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Drug Combinations; Enalapril; Evidence-Based Medicine; Humans; Hypertension; Renin-Angiotensin System; Treatment Outcome | 2010 |
[Treatment of arteril hypertension in patients with chronic kidney disease: a fixed combination of lercanidipine and enalapril].
Topics: Antihypertensive Agents; Blood Pressure; Dihydropyridines; Drug Combinations; Enalapril; Glomerular Filtration Rate; Humans; Hypertension; Renal Insufficiency, Chronic; Treatment Outcome | 2013 |
Fixed-dose lercanidipine and enalapril in field practice: a meta-analysis.
Topics: Antihypertensive Agents; Blood Pressure; Dihydropyridines; Drug Therapy, Combination; Enalapril; Essential Hypertension; Female; Humans; Hypertension; Male; Middle Aged; Outcome Assessment, Health Care | 2016 |
Dose-response effect of the lercanidipine/enalapril combination: a pooled analysis.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Dihydropyridines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Male; Middle Aged | 2016 |
Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Drug Combinations; Enalapril; Evidence-Based Medicine; Humans; Hypertension; Patient Satisfaction; Treatment Outcome | 2016 |
Antihypertensive treatment with calcium channel blockers and renal protection: focus on lercanidipine and lercanidipine/enalapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Enalapril; Humans; Hypertension; Kidney | 2022 |
14 trial(s) available for lercanidipine and enalapril
| Article | Year |
|---|---|
Diabetics with hypertension not controlled with ACE inhibitors: alternate therapies.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dihydropyridines; Drug Therapy, Combination; Enalapril; Female; Glycated Hemoglobin; Humans; Hypertension; Male; Metoprolol; Middle Aged; Regression Analysis; Vascular Resistance | 2001 |
Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dihydropyridines; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Single-Blind Method | 2006 |
Lercanidipine, enalapril and their combination in the treatment of elderly hypertensive patients: placebo-controlled, randomized, crossover study with four ABPM.
Topics: Aged; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Cross-Over Studies; Diastole; Dihydropyridines; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Placebos; Systole; Time Factors | 2007 |
Efficacy and tolerability of the fixed lercanidipine-enalapril combination in the treatment of patients with essential hypertension.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cohort Studies; Dihydropyridines; Drug Combinations; Enalapril; Female; Heart Rate; Humans; Hypertension; Lipids; Male; Middle Aged; Prospective Studies | 2010 |
Efficacy and safety of a fixed-dose combination of lercanidipine and enalapril in daily practice. A comparison of office, self-measured and ambulatory blood pressure.
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dihydropyridines; Drug Combinations; Enalapril; Female; Follow-Up Studies; Germany; Humans; Male; Prospective Studies; Surveys and Questionnaires; Treatment Outcome | 2011 |
Effects of enalapril/lercanidipine combination on some emerging biomarkers in cardiovascular risk stratification in hypertensive patients.
Topics: Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; CD40 Ligand; Dihydropyridines; Double-Blind Method; Drug Combinations; Enalapril; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Peroxidase; Risk Factors | 2014 |
Enalapril/lercanidipine combination on markers of cardiovascular risk: a randomized study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Calcium Channel Blockers; Dihydropyridines; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Humans; Hypertension; Italy; Lipids; Male; Risk Factors; Survival Rate; Treatment Outcome | 2014 |
Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension: a European randomized, controlled clinical trial.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Double-Blind Method; Drug Combinations; Enalapril; Female; Humans; Hypertension; Male; Medication Adherence; Middle Aged | 2014 |
Efficacy and safety of lercanidipine/enalapril fixed combination in Lebanon: a prospective observational study.
Topics: Adult; Antihypertensive Agents; Dihydropyridines; Drug Combinations; Enalapril; Female; Heart Rate; Humans; Hypertension; Lebanon; Lipids; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2015 |
Combination therapy with lercanidipine and enalapril reduced central blood pressure augmentation in hypertensive patients with metabolic syndrome.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Italy; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Treatment Outcome; Vascular Stiffness | 2017 |
Effects of the lercanidipine-enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Calcium Channel Blockers; Databases, Factual; Dihydropyridines; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Intention to Treat Analysis; Male; Middle Aged; Office Visits; Self Care | 2016 |
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Cross-Over Studies; Dihydropyridines; Double-Blind Method; Drug Therapy, Combination; Enalapril; Felodipine; Female; Heart Rate; Humans; Hypertension; Insulin Resistance; Male; Metabolome; Middle Aged; Norepinephrine; Obesity; Random Allocation; Sympathetic Nervous System | 2016 |
Lercanidipine valuable effect on urine protein losses: the RED LEVEL study.
Topics: Aged; Albuminuria; Amlodipine; Antihypertensive Agents; Blood Pressure; Dihydropyridines; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Kidney; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Prospective Studies | 2016 |
Differential effects of lercanidipine/enalapril versus amlodipine/enalapril and hydrochlorothiazide/enalapril on target organ damage and sympathetic activation in non-obese essential hypertensive subjects.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dihydropyridines; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Kidney; Male; Middle Aged; Sympathetic Nervous System; Vascular Stiffness | 2016 |
12 other study(ies) available for lercanidipine and enalapril
| Article | Year |
|---|---|
Determination of pK(a) values of some antihypertensive drugs by liquid chromatography and simultaneous assay of lercanidipine and enalapril in their binary mixtures.
Topics: Antihypertensive Agents; Chromatography, Liquid; Dihydropyridines; Enalapril; Limit of Detection | 2010 |
[Fixed combination enalapril/lercanidipine in routine treatment: consistent RR reduction with kidney protection].
Topics: Antihypertensive Agents; Dihydropyridines; Drug Combinations; Electrocardiography; Enalapril; Humans; Hypertension; Kidney Function Tests; Proteinuria | 2011 |
[ACE inhibitor and calcium antagonist in fixed combination: effective protection for hypertensive patients at risk].
Topics: Albuminuria; Antihypertensive Agents; Blood Pressure; Combined Modality Therapy; Dihydropyridines; Drug Combinations; Enalapril; Humans; Hypertension; Physical Fitness; Stroke | 2012 |
Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arterioles; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Diuretics; Drug Therapy, Combination; Enalapril; Essential Hypertension; Female; Humans; Hydrochlorothiazide; Hypertension; Kidney; Laser-Doppler Flowmetry; Male; Middle Aged; Oxidative Stress; Ultrasonography | 2014 |
Effect of antihypertensive treatments on insulin signalling in lympho-monocytes of essential hypertensive patients: a pilot study.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Dihydropyridines; Drug Combinations; Enalapril; Essential Hypertension; Female; Glucose Transporter Type 4; Humans; Hypertension; Insulin; Lymphocytes; Male; Middle Aged; Monocytes; Nifedipine; Pilot Projects; Signal Transduction; TOR Serine-Threonine Kinases | 2014 |
Efficacy and safety of a lercanidipine/enalapril fixed-dose combination in hypertensive patients in Portugal.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Dihydropyridines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Patient Safety; Portugal | 2014 |
Single-pill combination therapy in the initial treatment of marked hypertension: a propensity-matched analysis.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Dihydropyridines; Dose-Response Relationship, Drug; Drug Combinations; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Perindopril; Propensity Score; Ramipril; Retrospective Studies; Risk Factors; Telmisartan; Tetrazoles | 2015 |
[Effect of Fixed Lercanidipine/Enalapril Combination on 24-Hour Blood Pressure Proffie in Elderly Patients With Arterial Hypertension].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Humans; Hypertension; Male; Treatment Outcome | 2015 |
Vascular effects of the lercanidipine/enalapril combination: clinical relevance.
Topics: Antihypertensive Agents; Blood Pressure; Blood Vessels; Dihydropyridines; Drug Therapy, Combination; Enalapril; Humans; Hypertension | 2016 |
Comparison of lercanidipine plus hydrochlorothiazide vs. lercanidipine plus enalapril on micro and macrocirculation in patients with mild essential hypertension.
Topics: Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged | 2017 |
Effects on 24-hour blood pressure variability of ace-inhibition and calcium channel blockade as monotherapy or in combination.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; Enalapril; Female; Humans; Hypertension; Male; Middle Aged | 2018 |
Enalapril-lercanidipine combination induced leukocytoclastic vasculitis: A case report.
Topics: Dihydropyridines; Enalapril; Humans; Hypertension; Vasculitis, Leukocytoclastic, Cutaneous | 2021 |